Aspa Therapeutics is working to develop a safe and effective gene therapy for patients with Canavan disease, a rare condition caused by an inherited mutation of the ASPA gene.
Company Details
- Employees
- 4
- Address
- 3160 Porter Dr,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- aspatx.com
- Keywords
- canavan disease.
- HQ
- Palo Alto, California
Aspa Therapeutics Questions
Aspa Therapeutics's website is aspatx.com
Aspa Therapeutics's LinkedIn profile is https://www.linkedin.com/company/aspa-therapeutics
Aspa Therapeutics has
4 employees.
View email and phone details for 4
employees at Aspa Therapeutics.
Aspa Therapeutics's industry is
Biotechnology Research
Aspa Therapeutics's top competitors are
Bioeclipse Therapeutics, Inc,
Apogee Therapeutics,
Bluerock Therapeutics,
Alessa Therapeutics, Inc.,
Acurex Biosciences,
Voyager Therapeutics, Inc.,
Crinetics Pharmaceuticals,
Altay Therapeutics,
Bridgebio,
Sarepta Therapeutics.
Aspa Therapeutics's categories are Biotechnology Research
